Change is a constant theme for our annual Generics Bulletin Top 50 ranking of the world’s leading generics and biosimilars companies, and this year’s rundown of off-patent industry titans is no different.
The top 10 players in 2023’s roster are a different group to last year’s leadership table, with two firms that were present in 2022’s top 10 dropping out to make...